Originally published In Press as doi:10.1074/jbc.M411972200 on April 27, 2005
J. Biol. Chem., Vol. 280, Issue 28, 26113-26120, July 15, 2005
Nuclear Factor of Activated T Cells and Serum Response Factor Cooperatively Regulate the Activity of an
-Actin Intronic Enhancer*
Laura V. Gonzalez Bosc
,
Jeff J. Layne
,
Mark T. Nelson, and
David C. Hill-Eubanks
From the
Department of Pharmacology, College of Medicine, University of Vermont, Burlington, Vermont 05405
Expression of
-actin in smooth muscle cells (SMCs) is regulated, in part, by an intronic serum response factor (SRF)-binding CArG element. We have identified a conserved nuclear factor of activated T cells (NFAT) binding site that overlaps this CArG box and tested the hypothesis that this site plays a previously unrecognized role in regulating
-actin expression. A reporter construct prepared using a 56-bp region of the mouse
-actin first intron containing SRF, NFAT, and AP-1 sites (SNAP) acted as an enhancer element in the context of a minimal thymidine kinase promoter. Basal reporter activity following expression in SMCs was robust and sensitive to the calcineurin-NFAT pathway inhibitors cyclosporin A and FK506. Mutating either the NFAT or SRF binding site essentially abolished reporter activity, suggesting that both NFAT and SRF binding are required. Basal activity in non-smooth muscle HEK293 cells was SRF-dependent but NFAT-independent and
8-fold lower than that in SMCs. Activation of NFAT in HEK293 cells induced an
4-fold increase in activity that was dependent on the integrity of both NFAT and SRF binding sites. NFATc3·SRF complex formation, demonstrated by co-immunoprecipitation, was facilitated by the presence of SNAP oligonucleotide. Inhibition of the calcineurin-NFAT pathway decreased
-actin expression in cultured SMCs, suggesting that the molecular interaction of NFAT and SRF at SNAP may be physiologically relevant. These data provide the first evidence that NFAT and SRF may interact to cooperatively regulate SMC-specific gene expression and support a role for NFAT in the phenotypic maintenance of smooth muscle.
Received for publication, October 21, 2004
, and in revised form, April 15, 2005.
* This work was supported by National Institutes of Health Grants HL44455, HL63722, DDK065947, and DDK53832(to M. T. N.); a post-doctoral fellowship from the American Heart Association (to L. V. G. B.); National Institutes of Health Training Grant HL07944 (to J. J. L.); and a grant from the Totman Trust for Medical Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Both authors contributed equally to this work.
To whom correspondence should be addressed: Dept. of Pharmacology, University of Vermont, 89 Beaumont Ave., Burlington, VT 05405. Tel.: 802-656-2500; Fax: 802-656-4523; E-mail: David.Hill-Eubanks{at}uvm.edu.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Layne, M. Werner, D. Hill-Eubanks, and M. Nelson
NFATc3 regulates BK channel function in murine urinary bladder smooth muscle
Am J Physiol Cell Physiol,
September 1, 2008;
295(3):
C611 - C623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Deng, G. A. Dokshin, J. Lei, A. M. Goldsmith, K. N. Bitar, D. C. Fingar, M. B. Hershenson, and J. K. Bentley
Inhibition of Glycogen Synthase Kinase-3{beta} Is Sufficient for Airway Smooth Muscle Hypertrophy
J. Biol. Chem.,
April 11, 2008;
283(15):
10198 - 10207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Filosa, M. T. Nelson, and L. V. Gonzalez Bosc
Activity-dependent NFATc3 nuclear accumulation in pericytes from cortical parenchymal microvessels
Am J Physiol Cell Physiol,
December 1, 2007;
293(6):
C1797 - C1805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Nilsson, Z.-W. Sun, J. Nilsson, I. Nordstrom, Y.-W. Chen, J. D. Molkentin, D. Wide-Swensson, P. Hellstrand, M.-L. Lydrup, and M. F. Gomez
Novel blocker of NFAT activation inhibits IL-6 production in human myometrial arteries and reduces vascular smooth muscle cell proliferation
Am J Physiol Cell Physiol,
March 1, 2007;
292(3):
C1167 - C1178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Charvet, C. Houbron, A. Parlakian, J. Giordani, C. Lahoute, A. Bertrand, A. Sotiropoulos, L. Renou, A. Schmitt, J. Melki, et al.
New Role for Serum Response Factor in Postnatal Skeletal Muscle Growth and Regeneration via the Interleukin 4 and Insulin-Like Growth Factor 1 Pathways.
Mol. Cell. Biol.,
September 1, 2006;
26(17):
6664 - 6674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Barlow, P. Rose, R. A. Pulver-Kaste, and K. M. Lounsbury
Excitation-transcription coupling in smooth muscle
J. Physiol.,
January 1, 2006;
570(1):
59 - 64.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.